A Self Assessment Toolfor Donor Agencies
In: Improving Incentives in Donor Agencies (First Edition); Better Aid, S. 37-65
1103 Ergebnisse
Sortierung:
In: Improving Incentives in Donor Agencies (First Edition); Better Aid, S. 37-65
In: International review of the Red Cross: humanitarian debate, law, policy, action, Band 87, Heft 858, S. 367-373
ISSN: 1607-5889
AbstractFor decades it has been taboo to mention the role played by religious organizations in development cooperation. Today, however, there is growing awareness of the contribution that these organizations can make to sustainable development, just as there is of the risk they pose of abuse and conflict aggravation. Those involved in development therefore have to learn to cope with the double-edged nature of these organizations. Government donor agencies and faith-based organizations should jointly monitor their work in conflict-prone areas to ascertain whether it fosters peaceful settlement of conflict or whether, in fact, it aggravates the violence.
In: Journal of institutional economics, Band 8, Heft 3, S. 399-427
ISSN: 1744-1382
Abstract:This paper examines in depth one of the potential causes of the low performance of foreign aid; in particular, the role incentive structures within international donor agencies could play in leading to 'a push' to disburse money. This pressure to disburse money is termed as the 'Money-Moving Syndrome' (MMS). The theoretical analysis in this paper relies on the principal–agent theory to explore how donor agencies' institutional incentive systems may affect the characteristics of an optimal and efficient incentive contract and thus give rise to the MMS. The basic framework of the principal–agent theory was innovatively adapted to fit the organizational settings of donor agencies. The model concludes that the extent to which a performance measure based on the amount of aid allocated within a specific period of time would lead to the MMS and affect aid effectiveness depends on the level of 'institutional imperatives', the degree of aid agency's accountability for effectiveness, the level of corruption in recipient countries and the degree of difficulty to evaluate development activities.
In: Habitat international: a journal for the study of human settlements, Band 10, Heft 1-2, S. 11-19
In: Better aid
Literaturverz. S. 65
In: ILIRIA International Review, 2020, Vol. 10 (1) pp.106-133.
SSRN
Working paper
In: Journal of public administration, finance and law, Heft 22
ISSN: 2285-3499
In: Studies in family planning: a publication of the Population Council, Band 16, Heft 4, S. 239
ISSN: 1728-4465
In: Development Centre studies
In: OECD Publications 42,625
In: Japanese journal of political science, Band 8, Heft 2, S. 263
ISSN: 1474-0060
In: Development Policy Review, Band 36, S. O138-O158
SSRN
Abstract This article discusses the attempt undertaken by several development aid agencies since the turn of the century to integrate political economy assessments into their decision making on development assistance. The article discusses three such attempts: the Drivers of Change adopted by the UK's Department for International Development, the Strategic Governance and Corruption Analysis (SGACA) developed by the Dutch Directorate General for International Cooperation and the new thinking on political economy analysis, policy reform and political risk advanced by the World Bank. On the basis of a political-economic interpretation of development agencies, two main factors are found to hinder the successful application of political economy assessment. In the first place, the agencies' professional outlook leads them to see development in primarily technical terms. In the second place, the nature of incentives for development professionals leads them to resist the implementation of
BASE
In: Education and development
In: Third world quarterly, Band 33, Heft 3, S. 405-422
ISSN: 1360-2241
In: http://www.biomedcentral.com/1472-6939/17/71
Abstract Background Egg donor agencies are increasingly being used as part of IVF in the US, but are essentially unregulated, posing critical ethical and policy questions concerning how providers view and use them, and what the implications might be. Methods Thirty-seven in-depth interviews of approximately 1 h were conducted – with 27 IVF providers and 10 patients. Results Clinicians vary in their views and interactions concerning egg donor agencies, ranging widely in whether and how often they use agencies. Agencies may offer egg recipients increased choices, but raise ethical and other concerns regarding respect for donors as individuals (e.g., adequacy of informed consent), potential harms, justice (e.g., concerns about possible eugenics – by encouraging and facilitating selection and marketing of facts for offspring), and donors constituting a vulnerable group. The quality of agencies appears to vary considerably, from acceptable to problematic. Agencies' medical and psychological screenings of donors can range, and be minimal. Not all agencies adequately track donors' prior numbers of donations, or share the relevant records with clinics. Clinics may find that potential donors have genetic mutations and medical problems about which they were unaware. Yet agencies and clinics do not provide care for such donors, generating stress. Dissemination of donors' personal data can potentially threaten confidentiality. Questions emerge of whether increased monitoring/oversight of agencies may be beneficial. Conclusions These data, the first to examine providers' views and interactions regarding egg donor agencies, suggest wide variations in quality and use of agencies, and have critical implications for practice, policy, education and research. Given the potential limitations of the current model of self-regulation of agencies, the present data suggest needs to consider stronger professional guidelines or possible governmental regulations to establish, require and enforce higher standards for agencies to follow, regarding advertising to potential donors and recipients, arranging for appropriate informed consent concerning risks and benefits involved, and for quality control. Appropriate informed consent should be obtained from potential egg donors, including the fact that they may learn about mutations or medical problems about which they were unaware, but for which they will not receive treatment as part of this process. Enhancing understanding among the public-at-large about what egg donation entails may also be helpful.
BASE